New method developed for the precise production of human neural circuits in the laboratory
en-GBde-DEes-ESfr-FR

New method developed for the precise production of human neural circuits in the laboratory


How do the circuits of the human brain work – and what happens when they are disrupted? To investigate these questions, researchers at the Eye Clinic of the University Hospital Bonn (UKB) and the University of Bonn, together with colleagues from the University of Münster and Harvard Medical School, have developed an innovative platform that allows the function of neural networks to be studied in a targeted manner. The results have now been published in the journal ACS Nano.

Prof. Dr. Volker Busskamp, biotechnologist and research group leader at the UKB Eye Clinic, member of the ImmunoSensation² Cluster of Excellence and the Transdisciplinary Research Area (TRA) ‘Life & Health’ at the University of Bonn, and his team have developed a novel technology that allows human neural networks to be constructed in a targeted and reproducible manner for the first time. The method, called Single-Neuron Network Assembly Platform (SNAP), makes it possible to position nerve cells with single-cell precision and examine their electrical signals. This opens up a completely new approach to researching fundamental processes in the brain – and potentially also diseases such as epilepsy or cardiac arrhythmia.

Targeted neural circuits instead of random networks
Until now, in vitro models of the brain have often been based on randomly formed cell connections, which severely limits their reproducibility. The SNAP method, on the other hand, combines 3D-printed microfluidic channels with state-of-the-art laser and soft lithography technology. The individual cells are positioned in the channels with microscopic precision using a micropipette and a micromanipulator. The axon growth of the nerve cells can also be specifically controlled, resulting in clearly defined and reproducible neural networks. This allows neurons to be positioned exactly and electrical activity to be measured precisely.
‘With SNAP, we can design neural circuits from scratch,’ explains Busskamp. ‘This allows us to study networks with specific properties and to record processes that were previously difficult to access experimentally.’

First direct confirmation of so-called ephaptic coupling
One focus of the study was the investigation of ephaptic coupling – i.e. the interaction between neurons via their own electrical fields, independent of synaptic contacts. Such effects have previously been described mainly in theory, but could hardly be proven experimentally. With SNAP, direct experimental evidence of ephaptic coupling in a controlled human neural circuit has now been obtained for the first time. ‘The decisive factor was being able to control the cells at the single-cell level,’ explains Johannes Striebel, doctoral student and first author of the study. "That sounds trivial, but it is extremely challenging from a technical standpoint. It was only through this precision that we were able to show how electric fields influence signal transmission between neurons." It was found that this form of electrical communication influences the speed and timing of neural signals. Ephaptic coupling probably plays a role not only in the brain but also in the heart muscle and could be involved in diseases such as epilepsy or cardiac arrhythmia.

New opportunities for basic research and disease models
The platform allows the integration of different cell types and the precise observation of individual neurons, including optogenetic stimulation. It can be used both for basic research into information processing in the brain and for modelling disease-specific changes.
In the long term, SNAP could also be used in drug research or in the development of functional disease models. Due to its high sensitivity to synaptic antagonists, the method is particularly suitable for the analysis of neuroactive substances.

Funding from the Volkswagen Foundation
The underlying project, Functional Synthetic Human Neural Circuits by Prof. Dr. Volker Busskamp, has been funded with around 1.5 million euros since 2014 as part of a Freigeist Fellowship from the Volkswagen Foundation. This programme supports exceptional researchers who work at the interfaces of established disciplines and pursue innovative, high-risk research projects.

Busskamp's project investigated how the human brain functions in health and disease. To this end, the researchers combine neuroscience, stem cell research and bioengineering to artificially replicate functional neural circuits. Neurons are specifically generated from adult stem cells and connected to form reproducible networks, into which disease-causing mutations can also be introduced. This allows neurobiological mechanisms and potential therapeutic approaches to be researched precisely – right up to the vision of biological computers that process information as efficiently as the human brain.

Original publication: Johannes Striebel et al.: Reproducible Human Neural Circuits Printed with Single-Cell Precision Reveal the Functional Roles of Ephaptic Coupling, in: ACS Nano, October 2025; DOI: 10.1021/acsnano.5c11482
Johannes Striebel et al.: Reproducible Human Neural Circuits Printed with Single-Cell Precision Reveal the Functional Roles of Ephaptic Coupling, in: ACS Nano, October 2025; DOI:10.1021/acsnano.5c11482
Attached files
  • Fluorescence (left) and bright field image (right) of an artificially generated neural network with electrode structures for measuring nerve signals; Picture credits: University Hospital Bonn (UKB) / Johannes Striebel
  • Doctoral student Johannes Striebel and Prof. Dr. Volker Busskamp from the University Hospital Bonn (UKB) are developing a novel technology with the SNAP (Single-Neuron Network Assembly Platform) platform that allows human neural networks to be constructed and studied in a targeted and reproducible manner for the first time; Picture credits: University Hospital Bonn (UKB); Alessandro Winkler
Regions: Europe, Germany, United Kingdom
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement